Skip to main content
An official website of the United States government
Español
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

t-AML

A type of acute myeloid leukemia (AML) that is caused by previous treatment with chemotherapy or radiation therapy. t-AML is an aggressive (fast-growing) cancer in which there are too many myeloblasts (immature white blood cells) in the blood or bone marrow. t-AML usually occurs within 7 years after treatment. It is more common in adults. Also called therapy-related acute myeloid leukemia.
Search NCI's Dictionary of Cancer Terms